Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Ivy Leaf Extract

Also known as: Ivy leaf extract, English ivy leaf extract, Hedera helix

Overview

Ivy leaf extract, derived from the leaves of Hedera helix (common ivy), is a widely used herbal supplement primarily recognized for its efficacy in treating respiratory conditions such as cough and bronchitis. The extract's therapeutic properties are attributed to its rich content of saponins, particularly hederacoside C, which are believed to exert mucolytic and bronchodilatory effects. It is predominantly utilized for the symptomatic relief of acute cough associated with upper respiratory tract infections (URTIs). Extensive research, including numerous randomized controlled trials (RCTs) and meta-analyses, has consistently supported its effectiveness and favorable safety profile, often comparable to placebo. This robust evidence base has solidified its position as a reliable option for managing acute cough symptoms.

Benefits

Ivy leaf extract offers significant benefits for individuals experiencing acute cough and bronchitis. Its primary effect is a substantial reduction in cough intensity and bronchitis severity scores (BSS) in adults with acute respiratory tract infections (ARTIs). Meta-analyses, particularly involving the standardized dry extract EA 575®, demonstrate faster symptom relief compared to placebo, with noticeable improvements within 2 days and increasing over 7 days of treatment. For instance, a meta-analysis showed a BSS reduction of approximately 8.6 ± 0.2 points for ivy extract versus 6.2 ± 0.2 for placebo after 7 days (p < 0.001). Patients treated with ivy leaf extract also show a higher proportion of being cough-free at the end of treatment and during follow-up (18.1% vs. 9.3% at treatment end; 56.2% vs. 25.6% at follow-up). Beyond symptom reduction, it also contributes to an improved quality of life and patient-reported outcomes related to cough. These benefits are particularly relevant for adults aged 18-75 with acute cough due to URTIs or bronchitis, with statistically significant and clinically meaningful effect sizes.

How it works

The therapeutic actions of ivy leaf extract are primarily mediated by its saponin content. These compounds exhibit mucolytic activity by reducing the viscosity of mucus in the respiratory tract, thereby facilitating its easier expulsion (expectoration). Additionally, ivy leaf extract is believed to possess bronchodilatory properties, which involve the relaxation of bronchial smooth muscles, leading to improved airflow in the lungs. Anti-inflammatory effects may also contribute to its ability to alleviate respiratory symptoms. Standardized formulations, such as EA 575®, are absorbed orally and demonstrate good bioavailability, allowing the active compounds to exert their effects on the respiratory system.

Side effects

Ivy leaf extract is generally well-tolerated, with a safety profile comparable to that of a placebo. No common side effects (occurring in >5% of users) have been reported at a significant frequency. Uncommon side effects, affecting 1-5% of users, may include mild gastrointestinal discomfort (such as nausea or diarrhea) or mild allergic reactions (e.g., skin rash). Rare side effects, occurring in less than 1% of users, are anecdotally reported hypersensitivity reactions. There are no significant drug interactions documented with ivy leaf extract. Contraindications include a known allergy to ivy or other plants in the Araliaceae family. While generally considered safe for adults, specific safety data for children, pregnant women, and breastfeeding women are limited, and use in these populations should be approached with caution and under medical supervision. Overall, serious adverse events are rare, and the extract is considered safe for short-term use within recommended dosages.

Dosage

For optimal efficacy, the recommended dosage for standardized dry ivy leaf extract (e.g., EA 575®) is typically 105 mg per day. This can be administered as three 35 mg doses throughout the day. The optimal dosage range for adults is generally between 105-210 mg daily, divided into two or three doses, for a duration of 7 days or as clinically indicated by symptoms. While no established maximum safe dose exists, standard dosing has been shown to be well-tolerated and effective. Ivy leaf extract should be taken orally, preferably with water, with doses spaced evenly throughout the day to maintain consistent therapeutic levels. The use of standardized dry extracts, such as EA 575®, is preferred to ensure consistent potency and efficacy. No special cofactors are required for absorption, as oral bioavailability is adequate.

FAQs

Is ivy leaf extract safe for long-term use?

Most studies focus on short-term use (7-14 days), demonstrating its safety and tolerability within this period. Long-term safety data are limited, so it's primarily recommended for acute cough relief.

How quickly does it work?

Symptom relief can be observed within 2 days of starting treatment, with significant and continued improvement typically seen by 7 days of consistent use.

Can it be used with other cough medicines?

It is generally considered safe to use with other medications, but it's advisable to consult a healthcare provider to avoid potential overlapping active ingredients or interactions.

Is organic ivy leaf extract more effective?

There is no direct evidence suggesting that organic ivy leaf extract is more effective than conventionally grown extract. Efficacy primarily depends on the standardization and overall quality of the extract, not its organic status.

Research Sources

https://www.efsm.online/int_en/article-overview/108/2023/promoted-to-the-highest-evidence-class-meta-analysis-supports-the-evidence-for-ea-575-r-in-treating-acute-cough – This systematic review and meta-analysis elevated EA 575® to the highest evidence class (Ia) for cough treatment. It found significant symptom relief and patient-reported benefits, confirming consistent findings across multiple studies despite some heterogeneity.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9681772/ – This meta-analysis of two double-blind, placebo-controlled RCTs (n=390) demonstrated significant bronchitis severity score (BSS) reduction with EA 575® compared to placebo. It showed faster recovery and no significant safety concerns over 7 days of treatment and 7 days of follow-up, highlighting robust methodology.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8275562/ – This systematic review of RCTs and controlled trials concluded that ivy leaf extract is effective and safe for acute cough and bronchitis. It reported improvements in spirometric and clinical outcomes, noting that while some studies were industry-funded, their findings were independently verified, indicating moderate to high quality.
https://www.pharmacist.com/Blogs/CEO-Blog/ivy-leaf-for-cough-relief – This blog post from the American Pharmacists Association provides a general overview of ivy leaf extract's use for cough relief. It summarizes its traditional and modern applications, supporting its role as an expectorant and antitussive.
https://www.semanticscholar.org/paper/Systematic-Review-of-Clinical-Trials-Assessing-the-Holzinger-Chenot/235cffacbc85ae14e8064ab763bfab81bf854094 – This systematic review assessed clinical trials on ivy leaf extract, confirming its efficacy and safety for respiratory conditions. It provides a comprehensive overview of the evidence base, supporting its use in managing cough and bronchitis symptoms.